These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
434 related articles for article (PubMed ID: 17592641)
1. Adoptively transferred human lung tumor specific cytotoxic T cells can control autologous tumor growth and shape tumor phenotype in a SCID mouse xenograft model. Oflazoglu E; Elliott M; Takita H; Ferrone S; Henderson RA; Repasky EA J Transl Med; 2007 Jun; 5():29. PubMed ID: 17592641 [TBL] [Abstract][Full Text] [Related]
2. Antitumor cytotoxic T-lymphocyte response in human lung carcinoma: identification of a tumor-associated antigen. Mami-Chouaib F; Echchakir H; Dorothée G; Vergnon I; Chouaib S Immunol Rev; 2002 Oct; 188():114-21. PubMed ID: 12445285 [TBL] [Abstract][Full Text] [Related]
3. Evidence for cytotoxic T lymphocyte response against human lung cancer: reconstitution of antigenic epitope with peptide eluted from lung adenocarcinoma MHC class I. Calhoun RF; Naziruddin B; Enriquez-Rincon F; Duffy BF; Ritter JM; Sundaresan S; Patterson GA; Cooper JD; Mohanakumar T Surgery; 2000 Jul; 128(1):76-85. PubMed ID: 10876189 [TBL] [Abstract][Full Text] [Related]
4. Adoptive transfer of natural killer cells promotes the anti-tumor efficacy of T cells. Goding SR; Yu S; Bailey LM; Lotze MT; Basse PH Clin Immunol; 2017 Apr; 177():76-86. PubMed ID: 27377534 [TBL] [Abstract][Full Text] [Related]
5. Human cytotoxic T-cells suppress the growth of spontaneous melanoma metastases in SCID/hu mice. Sabzevari H; Reisfeld RA Cancer Res; 1993 Oct; 53(20):4933-7. PubMed ID: 8402683 [TBL] [Abstract][Full Text] [Related]
6. A HLA-A2-restricted CTL epitope induces anti-tumor effects against human lung cancer in mouse xenograft model. Sher YP; Lin SI; Chen IH; Liu HY; Lin CY; Chiang IP; Roffler S; Chen HW; Liu SJ Oncotarget; 2016 Jan; 7(1):671-83. PubMed ID: 26621839 [TBL] [Abstract][Full Text] [Related]
7. In vivo antitumor function of tumor antigen-specific CTLs generated in the presence of OX40 co-stimulation in vitro. Pham Minh N; Murata S; Kitamura N; Ueki T; Kojima M; Miyake T; Takebayashi K; Kodama H; Mekata E; Tani M Int J Cancer; 2018 Jun; 142(11):2335-2343. PubMed ID: 29313971 [TBL] [Abstract][Full Text] [Related]
8. Human effector T cells derived from central memory cells rather than CD8(+)T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy. Wu F; Zhang W; Shao H; Bo H; Shen H; Li J; Liu Y; Wang T; Ma W; Huang S Cancer Lett; 2013 Oct; 339(2):195-207. PubMed ID: 23791878 [TBL] [Abstract][Full Text] [Related]
9. Human telomerase reverse transcriptase-transduced human cytotoxic T cells suppress the growth of human melanoma in immunodeficient mice. Verra NC; Jorritsma A; Weijer K; Ruizendaal JJ; Voordouw A; Weder P; Hooijberg E; Schumacher TN; Haanen JB; Spits H; Luiten RM Cancer Res; 2004 Mar; 64(6):2153-61. PubMed ID: 15026357 [TBL] [Abstract][Full Text] [Related]
11. Small cell lung carcinomas express shared and private tumor antigens presented by HLA-A1 or HLA-A2. Yamazaki K; Spruill G; Rhoderick J; Spielman J; Savaraj N; Podack ER Cancer Res; 1999 Sep; 59(18):4642-50. PubMed ID: 10493519 [TBL] [Abstract][Full Text] [Related]
12. In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer. Santin AD; Hermonat PL; Ravaggi A; Bellone S; Pecorelli S; Cannon MJ; Parham GP Am J Obstet Gynecol; 2000 Sep; 183(3):601-9. PubMed ID: 10992180 [TBL] [Abstract][Full Text] [Related]
13. Artificial antigen-presenting cells expressing AFP(158-166) peptide and interleukin-15 activate AFP-specific cytotoxic T lymphocytes. Sun L; Guo H; Jiang R; Lu L; Liu T; Zhang Z; He X Oncotarget; 2016 Apr; 7(14):17579-90. PubMed ID: 27007051 [TBL] [Abstract][Full Text] [Related]
14. Autologous high-killing cytotoxic T lymphocytes against human lung cancer are induced using interleukin (IL)-1beta, IL-2, IL-4, and IL-6: possible involvement of dendritic cells. Saijo Y; Hong X; Tanaka M; Tazawa R; Liu SQ; Saijo K; Ohno T; Koike K; Ohkuda K; Satoh K; Nukiwa T Clin Cancer Res; 1999 May; 5(5):1203-9. PubMed ID: 10353758 [TBL] [Abstract][Full Text] [Related]
15. Adoptive transfer of an anti-MART-1(27-35)-specific CD8+ T cell clone leads to immunoselection of human melanoma antigen-loss variants in SCID mice. Lozupone F; Rivoltini L; Luciani F; Venditti M; Lugini L; Cova A; Squarcina P; Parmiani G; Belardelli F; Fais S Eur J Immunol; 2003 Feb; 33(2):556-66. PubMed ID: 12645955 [TBL] [Abstract][Full Text] [Related]
16. Development of adoptive immunotherapy with KK-LC-1-specific TCR-transduced γδT cells against lung cancer cells. Ichiki Y; Shigematsu Y; Baba T; Shiota H; Fukuyama T; Nagata Y; So T; Yasuda M; Takenoyama M; Yasumoto K Cancer Sci; 2020 Nov; 111(11):4021-4030. PubMed ID: 32780528 [TBL] [Abstract][Full Text] [Related]
17. Differential effect of high doses versus low doses of interleukin-12 on the adoptive transfer of human specific cytotoxic T lymphocyte in autologous lung tumors engrafted into severe combined immunodeficiency disease-nonobese diabetic mice: relation with interleukin-10 induction. Asselin-Paturel C; Megherat S; Vergnon I; Echchakir H; Dorothée G; Blesson S; Gay F; Mami-Chouaib F; Chouaib S Cancer; 2001 Jan; 91(1):113-22. PubMed ID: 11148567 [TBL] [Abstract][Full Text] [Related]
18. Tracking in vivo migration and distribution of antigen-specific cytotoxic T lymphocytes by 5,6-carboxyfluorescein diacetate succinimidyl ester staining during cancer immunotherapy. Xu WL; Li SL; Wen M; Wen JY; Han J; Zhang HZ; Gao F; Cai JH Chin Med J (Engl); 2013 Aug; 126(16):3019-25. PubMed ID: 23981604 [TBL] [Abstract][Full Text] [Related]
19. Induction of antitumor cytotoxic lymphocytes using engineered human primary blood dendritic cells. Wu L; Zhang H; Jiang Y; Gallo RC; Cheng H Proc Natl Acad Sci U S A; 2018 May; 115(19):E4453-E4462. PubMed ID: 29674449 [TBL] [Abstract][Full Text] [Related]
20. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells. Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]